Clinical Trial Update: Afatinib in Locally Advanced and Metastatic Chordoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Afatinib for locally advanced and metastatic chordoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Chordoma | Phase 2 | Status: COMPLETED